Physician profile
Devon Lee Losch
NPI 1144885013
$442.29
in general payments reported to CMS, 2019-2025
16 companies · $40.48 in 2025
The $40.48 reported for 2025 was less than what a typical Physician Assistant provider received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $21.36 · 2022: $196 · 2023: $185 · 2025: $40.48.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $225.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $225.33 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $100.49 | 2022-2023 | Ozempic, Rybelsus |
| Hologic Sales and Service, LLC | $40.48 | 2025 | Novasure |
| Janssen Pharmaceuticals, INC | $34.32 | 2023 | Xarelto |
| Merck Sharp & Dohme LLC | $31.31 | 2023 | Dificid |
| Ibsa Pharma INC. | $29.14 | 2022 | |
| Otsuka America Pharmaceutical, INC. | $28.75 | 2023 | Rexulti, Nuedexta |
| Abbvie INC. | $28.29 | 2022-2023 | |
| Biohaven Pharmaceutical Holding Company LTD. | $24.06 | 2022 | |
| Sanofi-Aventis U.S. LLC | $21.36 | 2021 | |
| Novartis Pharmaceuticals Corporation | $19.60 | 2022 | |
| Lilly USA, LLC | $17.27 | 2022 | |
| Amgen INC. | $14.29 | 2022 | |
| Nestle Healthcare Nutrition INC. | $13.89 | 2022 | |
| Shield Therapeutics INC | $13.62 | 2023 | Accrufer |
| Daiichi Sankyo INC. | $13.14 | 2022 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Avanir Pharmaceuticals, INC. | $12.28 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Devon Losch listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.